We don't know, last February it was the IND that drove the price, now it's the approval to proceed with clinical trails. After a drug that qualifies for Orphan designation is going through clinical trails, you wont see the PPS dip like this.
The opinions, comments, or concerns, expressed herein, are solely that of 'd5wr59mfi8'; They're not to be misconstrued as any form of advice, and any suggestions should not be followed.